Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
June 13, 2023 at 04:35 pm EDT
Share
Rafael Holdings, Inc. reported earnings results for the third quarter and nine months ended April 30, 2023. For the third quarter, the company reported sales was USD 0.071 million compared to USD 0.076 million a year ago. Revenue was USD 0.071 million compared to USD 0.076 million a year ago. Net loss was USD 1.44 million compared to USD 5.53 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.25 a year ago. Basic loss per share was USD 0.06 compared to USD 0.28 a year ago.
For the nine months, sales was USD 0.211 million compared to USD 0.221 million a year ago. Revenue was USD 0.211 million compared to USD 0.341 million a year ago. Net loss was USD 3.1 million compared to USD 119.87 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 6.07 a year ago. Basic loss per share was USD 0.14 compared to USD 6.16 a year ago.
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.
RAFAEL HOLDINGS, INC. 
